Patent directory · USPTO A61K / A61P
Patents matching “The United States of America”
3,063 pharma patents match "The United States of America" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 3,063 pharmaceutical patents matching "The United States of America" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12122843
High affinity monoclonal antibodies targeting glypican-1 and methods of use
granted -
US 12102671
Method of vaccination with an attenuated RSV vaccine formulation
granted -
US 12097196
Dopamine D3 receptor selective antagonists/partial agonists and uses thereof
granted -
US 12083246
Composite gels and methods of use thereof
granted -
US 12084489
Antibodies and methods for the diagnosis, prevention, and treatment of Epstein Barr virus infection
granted -
US 12077572
Monoclonal antibody for spike protein of middle east respiratory syndrome coronavirus, and use thereof
granted -
US 12071632
Chimeric vectors
granted -
US 12070495
HIV RNA vaccines
granted -
US 12071636
Pasteurella multocida strains and vaccines having hyaC and nanP deletions
granted -
US 12064514
Ultrasound-sensitive peptide particles for spatially resolved molecule delivery
granted -
US 12064472
Southern cattle tick vaccine product
granted -
US 12059418
Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria
granted -
US 12059413
Methods of inhibiting viruses using compositions targeting TSG101-ubiquitin interaction
granted -
US 12054519
Vaccine candidates for human respiratory syncytial virus (RSV) having attenuated phenotypes
granted -
US 12053519
HIV-1 Env fusion peptide nanoparticle carrier conjugates and their use
granted -
US 12054749
Attenuation of human respiratory syncytial virus by genome scale codon-pair deoptimization
granted -
US 12053520
Glycan-masked engineered outer domains of HIV-1 gp120 and their use
granted -
US 12043660
10E8 neutralizing antibody variants that bind to the MPER region of HIV-1 GP41 and their use
granted -
US 12037607
Methods of preparing hematopoietic progenitor cells in vitro
granted -
US 12029794
Virus-like particle conjugates for diagnosis and treatment of tumors
granted -
US 12018045
17-beta-hydroxywithanolides and use thereof in treating cancer
granted -
US 12012455
Human monoclonal antibodies specific for FLT3 and uses thereof
granted -
US 12012463
High affinity monoclonal antibodies targeting glypican-2 and uses thereof
granted -
US 12012438
Brachyury deletion mutants, non-yeast vectors encoding brachyury deletion mutants, and their use
granted